FDA warn­ing let­ters de­tail is­sues for man­u­fac­tur­ing sites in the US and In­dia

3 years ago
Pharma
FDA+

No­vo Nordisk drops two pro­grams as it plots We­govy come­back

3 years ago
Pharma

Al­lo­gene Over­land Bio­pharm com­pletes Shang­hai fa­cil­i­ty to man­u­fac­ture CAR-T prod­ucts

3 years ago
Pharma
Cell/Gene Tx

CVS, Wal­greens and Wal­mart reach near­ly $12B set­tle­ment over opi­oid epi­dem­ic

3 years ago
Law

For months Biden has tout­ed his win over phar­ma in the elec­tion lead-up. Will it help?

3 years ago
FDA+
Law

Sur­face On­col­o­gy lays off 20% as biotech halts CD39 work on one of its ‘crown jew­els’

3 years ago
People
R&D

In spin­ning out can­cer pipeline, Alk­er­mes cites In­fla­tion Re­duc­tion Ac­t's hy­po­thet­i­cal in­cen­tives for bi­o­log­ics R&D

3 years ago
Deals
R&D

Basilea’s can­cer pipeline slim­down con­tin­ues; Aque­s­tive looks to out­li­cense seizure drug in US

3 years ago
News Briefing

Rigel churns out an­oth­er late-stage clin­i­cal fail­ure — this time in Covid-19

3 years ago
R&D
Coronavirus

An NK cell ther­a­py biotech pulls IPO am­bi­tions weeks af­ter sec­ond tri­al clear­ance

3 years ago
Financing
Startups

CSL stacks up $4.5B in chips — with a $200M ante — to wa­ger on the next-gen mR­NA wave

3 years ago
Deals

ICER says it's fair for Bio­Marin and CSL to price in­com­ing he­mo­phil­ia gene ther­a­pies at $2M-$3M

3 years ago
Cell/Gene Tx

Up­dat­ed: GSK nabs pri­or­i­ty re­view on RSV vac­cine, kicks off show­down with Pfiz­er — while 'set­ting the bar high' on ...

3 years ago
R&D
Pharma

CFIUS re­view trig­gers de­lay on F-star's sale to Chi­nese play­er

3 years ago
Deals
China

Lead­ing a $60M launch round, RA Cap­i­tal backs an­oth­er 'toad ven­om' start­up

3 years ago
Financing
Startups

Ex­elix­is shells out $100M cash in a pair of deals, shoot­ing for dif­fer­ent takes on CD47, AD­Cs

3 years ago
Deals

Amid rev­enue dip, Pfiz­er CEO Al­bert Bourla is fo­cused on 'what's nex­t'

3 years ago
Pharma

FDA warns Ama­zon again for sell­ing un­ap­proved drugs on­line

3 years ago
FDA+

New JA­MA study digs in­to the rise of stack­ing FDA’s ex­pe­dit­ed pro­grams and des­ig­na­tions for new drugs

3 years ago
FDA+

Eli Lil­ly plans to make tirzepatide next big thing as phar­ma ex­pe­ri­ences 'un­prece­dent­ed' de­mand for the drug

3 years ago
Pharma

FDA clar­i­fies when spon­sors' ex­pand­ed ac­cess poli­cies need to be made pub­lic

3 years ago
FDA+

#CPHI22: As Sam­sung’s new plant comes on­line, it looks to ex­pand in Ko­rea and be­yond

3 years ago
Pharma
Manufacturing

HHS re­news 'call to ac­tion' with Covid boost­er ad spots

3 years ago
Pharma
Coronavirus

Col­lege ath­lete deals and phar­ma? Dex­com tests the wa­ters in a first move that opens new spokesper­son doors for ...

3 years ago
Pharma
Marketing
First page Previous page 429430431432433434435 Next page Last page
A service from the Financial Times